Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S831

Introduced
2/27/25  

Caption

To ensure access to prescription medication and community pharmacies

Impact

The enactment of Senate Bill 831 is projected to positively impact state laws by enforcing regulations that protect community pharmacies from practices such as 'pharmacy steering'—the illegal channeling of prescriptions towards pharmacies where pharmacy benefit managers hold ownership interests. This measure aims to standardize reimbursement processes and ensure that all pharmacies can provide medications equitably, thus fostering a more competitive and consumer-friendly healthcare environment. By mandating that reimbursement rates are equalized across both affiliated and non-affiliated pharmacies, the bill aims to enhance market fairness.

Summary

Senate Bill 831 aims to ensure better access to prescription medications and support community pharmacies within the Commonwealth of Massachusetts. This legislation seeks to amend Chapter 175 by introducing provisions that govern contracts for community pharmacy services, enfocing equitable practices around medication costs, and promoting transparency between pharmacy benefit managers and pharmacies. A significant aspect of the bill is its stress on ensuring that reimbursement for generic medications does not artificially disadvantage non-affiliated community pharmacies compared to those affiliated with pharmacy benefit managers.

Contention

Key points of contention surrounding Senate Bill 831 include concerns over the operational impacts it might have on pharmacy benefits managers and the broader pharmaceutical market landscape. Critics may argue that the increased regulation could lead to unintended consequences such as reduced incentives for pharmacy benefit managers to negotiate lower drug prices. Additionally, there is a concern about how tightly the provisions would be enforced and whether this might stifle innovation or adaptability within pharmacy benefits management systems. Supporters, on the other hand, frame these regulations as essential for safeguarding patient access to necessary medications while promoting fairness in the healthcare market.

Companion Bills

No companion bills found.

Previously Filed As

MA S715

To ensure access to prescription medications

MA H3587

To ensure access to prescription medications

MA H945

To ensure prescription drug cost transparency and affordability

MA S3012

Relative to pharmaceutical access, costs and transparency

MA S2499

Relative to pharmaceutical access, costs and transparency

MA S2520

Relative to pharmaceutical access, costs and transparency

MA S2492

Relative to pharmaceutical access, costs and transparency

MA S749

Relative to pharmaceutical access, costs and transparency

MA H1150

To ensure access to generic medication

MA S630

Ensuring access to specialty medications

Similar Bills

NJ S3842

"Patient and Provider Protection Act."

NJ A4953

"Patient and Provider Protection Act."

LA HB432

Provides for the regulation of pharmacy services administrative organizations (OR +$88,000 SG EX See Note)

LA HB387

Provides for the regulation of pharmacy services administrative organizations

AR SB593

To Amend The Arkansas Pharmacy Benefits Manager Licensure Act; And To Create The Pharmacy Services Administrative Organization Act.

CA AB913

Pharmacy benefit managers.

AR SB475

To Establish The Pharmacy Services Administrative Organization Act; And To Regulate Pharmacy Services Administrative Organizations.

CA SB966

Pharmacy benefits.